Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

Mike Frazier was living the dream. The 2013 graduate of Frederick County’s Millbrook High School moved to Seattle in 2022 ...

Neurona Therapeutics has gained $102m to support the advancement of its investigational cell therapy, NRTX-1001, into Phase III testing for drug-resistant mesial temporal lobe epilepsy (MTLE). The ...

In ‘The Mind Electric’ (Washington Square, June), the neurologist explores the roots of neurological disease and the ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Researchers identified walking impairment and malarial disease sustained by Tutankhamun, supported by the discovery of canes ...